Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jan Barendregt"'
Autor:
Tan Nhut Doan, Jan Barendregt
Publikováno v:
Swiss Medical Weekly, Vol 149, Iss 1920 (2019)
BACKGROUND Trastuzumab has a large financial impact on the average cost of breast cancer treatment. This study reassessed the cost-effectiveness of listing the drug on the subsidised Australian Pharmaceutical Benefits Scheme. METHODS Using a cont
Externí odkaz:
https://doaj.org/article/6749c72f66264d72a404d6811f500ae0
Autor:
Stephanie K. Tanamas, Evelyn Wong, Kathryn Backholer, Asnawi Abdullah, Rory Wolfe, Jan Barendregt, Anna Peeters
Publikováno v:
Australian and New Zealand Journal of Public Health, Vol 40, Iss 6, Pp 579-581 (2016)
Abstract Objective: To compare a simple measure ‐ age of onset of obesity ‐ to an obese‐years construct (a product of duration and magnitude of obesity) as risk factors for type 2 diabetes. Method: Participants from the Framingham Heart Study w
Externí odkaz:
https://doaj.org/article/0bc5d5f6a6b341a587a13ab7c3d7f827
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 6, Iss 3, p e1538 (2012)
INTRODUCTION: Trachoma is a disease that can lead to visual impairment and ultimately blindness. Previous estimates of health losses from trachoma using the Global Burden of Disease methodology have not, however, included the stage prior to visual im
Externí odkaz:
https://doaj.org/article/56bcab1319f144b88cecdcb619f86589
Autor:
Tony Blakely, Nick Wilson, Diana Sarfati, Jan Barendregt, Matt Boyd, Giorgi Kvizhinadze, Melissa McLeod
Background: Screening programs consistently underserve indigenous populations despite a higher overall burden of cancer. In this study, we explore the likely health gains and cost-effectiveness of a national colorectal cancer screening program for th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e8fc32afdf7465f83b668de089e35aa
https://doi.org/10.1158/1055-9965.c.6515524.v1
https://doi.org/10.1158/1055-9965.c.6515524.v1
Autor:
Tony Blakely, Nick Wilson, Diana Sarfati, Jan Barendregt, Matt Boyd, Giorgi Kvizhinadze, Melissa McLeod
S1 Table 1 Values of transition probability estimates and the 95% credible intervals for the natural history parameters; SFig 1 Model predicted versus observed average colorectal cancer mortality counts per year (2007-2010) by age, sex and ethnicity;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2295709c4012c3c921f71051dc10f5f2
https://doi.org/10.1158/1055-9965.22436662.v1
https://doi.org/10.1158/1055-9965.22436662.v1
Autor:
Jan Barendregt, Tan Nhut Doan
Publikováno v:
Swiss Medical Weekly.
Background Trastuzumab has a large financial impact on the average cost of breast cancer treatment. This study reassessed the cost-effectiveness of listing the drug on the subsidised Australian Pharmaceutical Benefits Scheme. Methods Using a continuo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::709b2093a64ea5c83e42f2469ad17046
https://doi.org/10.4414/smw.2019.20082
https://doi.org/10.4414/smw.2019.20082
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Orthopaedics. 39:593-594
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63ef754bb46e9fafc2190e5ba8424d16
https://doi.org/10.1007/s00264-014-2659-5
https://doi.org/10.1007/s00264-014-2659-5
Autor:
Jan Barendregt, Alewijn Ott
Publikováno v:
European Journal of Epidemiology; Oct2005, Vol. 20 Issue 10, p827-832, 6p
Autor:
Michelle Elisabeth Kruijshaar, Jan Barendregt, Theo Vos, Ron de Graaf, Jan Spijker, Gavin Andrews
Publikováno v:
European Journal of Epidemiology; Jan2005, Vol. 20 Issue 1, p103-111, 9p